Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Development, 2022
Coupled myovascular expansion directs cardiac growth and regeneration

DeBenedittis P., Karpurapu A., Henry A. et al.

Olink Target 96CVDPathophysiologyPlasma

British Journal of Cancer, 2022
Breast density is strongly associated with multiparametric magnetic resonance imaging biomarkers and pro-tumorigenic proteins in situ

Lundberg P., Forsgren M., Tellman J. et al.

Olink Target 96OncologyPathophysiologyMicrodialysis Fluid

Clinical and Experimental Immunology, 2022
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

Valli A., Kuuliala K., Virtanen A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Diabetologia, 2022
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women

Mendham A., Micklesfield L., Karpe F. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

Clinical & Experimental Allergy, 2022
Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma

Kere M., Klevebro S., Hernandez‐Pacheco N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient Stratification

Science Translational Medicine, 2022
A shift in lung macrophage composition is associated with COVID-19 severity and recovery

Chen S., Park M., Del Valle D. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Journal of Critical Care, 2022
Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort

Linné E., Elfström A., Åkesson A. et al.

Olink Target 96Infectious DiseasesNephrologyPathophysiologyPatient StratificationPlasma

Nature Cardiovascular Research, 2022
Age-dependent sex differences in cardiometabolic risk factors

Zhernakova D., Sinha T., Andreu-Sánchez S. et al.

Olink Target 96CVDPatient StratificationPlasma

ESC Heart Failure, 2022
Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

Bracun V., van Essen B., Voors A. et al.

Olink Target 96CVDPathophysiologyPlasma

ESC Heart Failure, 2022
Elevated plasma WIF‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension

Kania K., Ahmed A., Ahmed S. et al.

Olink Target 96CVDPatient StratificationPlasma

Diabetes, Obesity and Metabolism, 2022
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial

Razaghizad A., Sharma A., Ni J. et al.

Olink Target 96CVDPatient StratificationPlasma

Alzheimer's Research & Therapy, 2022
Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study

Trares, K., Bhardwaj et al.

Olink Target 96NeurologyPatient StratificationPlasma

Clinical Kidney Journal, 2022
The use of plasma biomarker-derived clusters for clinicopathologic phenotyping: results from the Boston Kidney Biopsy Cohort

Schmidt I., Myrick S., Liu J. et al.

Olink Target 96NephrologyPatient StratificationPlasma

Journal of Clinical Immunology, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors

Borgström E., Edvinsson M., Pérez L. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPlasma

Journal of the American Society of Nephrology, 2022
Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity

Sun Z., Zhang Z., Banu K. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Neurology Neuroimmunology & Neuroinflammation, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis

Thonhoff J., Berry J., Macklin E. et al.

Olink Target 48NeurologyPathophysiologySerum

International Journal of Cancer, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression

Tzaridis T., Weller J., Bachurski D. et al.

Olink Target 96OncologyTechnical EvaluationEV Lysate

European Heart Journal, 2022
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

Zannad F., Ferreira J., Butler J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

eBioMedicine, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma

Rossi N., Lee K., Bermudez M. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum

Science Advances, 2022
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods

Katz D., Robbins J., Deng S. et al.

Olink Explore 3072/384Wider Proteomics StudiesTechnical EvaluationPlasma

3144 publications